Stock PUR PURE BIOLOGICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Pure Biologics S.A.

Equities

PUR

PLPRBLG00010

Delayed Warsaw S.E.
Other stock markets
 10:49:13 2024-06-28 EDT 		5-day change 1st Jan Change
8.59 PLN -0.81% Intraday chart for Pure Biologics S.A. +1.66% -32.04%
05-15 Pure Biologics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pure Biologics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Presage Announces Collaboration with Pure Biologics to Investigate Oncology Agents in Early Development with CIVO® Technology
CI
Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna.
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Pure Biologics Sp?lka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development
CI
Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PUR Stock
  4. News Pure Biologics S.A.